Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    The Methamphetamine-Associated Psychosis Spectrum: a Clinically Focused Review

    Access Status
    Fulltext not available
    Authors
    Arunogiri, S.
    McKetin, Rebecca
    Verdejo-Garcia, A.
    Lubman, D.
    Date
    2018
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Arunogiri, S. and McKetin, R. and Verdejo-Garcia, A. and Lubman, D. 2018. The Methamphetamine-Associated Psychosis Spectrum: a Clinically Focused Review. International Journal of Mental Health and Addiction.
    Source Title
    International Journal of Mental Health and Addiction
    DOI
    10.1007/s11469-018-9934-4
    ISSN
    1557-1874
    School
    National Drug Research Institute (NDRI)
    URI
    http://hdl.handle.net/20.500.11937/68651
    Collection
    • Curtin Research Publications
    Abstract

    © 2018 Springer Science+Business Media, LLC, part of Springer Nature. Methamphetamine use is a global concern, and methamphetamine-associated psychosis (MAP) is a particular harm resulting from regular use of the drug that causes significant distress and burden on health and social services. This paper aims to provide a clinically focussed and up-to-date overview of the prevalence, risk factors, and clinical and cognitive features of MAP. The prevalence of MAP ranges between 15 and 30% in recreational settings and up to 60% in some inpatient treatment settings, with up to a third of people with MAP later diagnosed with persistent psychotic disorders. The frequency of methamphetamine use and severity of dependence are the most consistent risk factors for MAP, but other predictors such as genetic vulnerability, a family history of psychotic illness, or trauma also play a role. People with MAP can vary in their presentation, from brief delusional experiences, to persistent psychosis characterised by first-rank symptoms and cognitive impairment. Contemporary conceptualisations of MAP need to incorporate this spectrum of clinical presentations in order to inform clinical decision-making, service provision, and research directions.

    Related items

    Showing items related by title, author, creator and subject.

    • A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence
      McKetin, Rebecca ; Dean, O.M.; Turner, A.; Kelly, P.J.; Quinn, B.; Lubman, D.I.; Dietze, Paul ; Carter, G.; Higgs, Peter ; Baker, A.L.; Sinclair, B.; Reid, D.; Manning, V.; Te Pas, N.; Liang, Wenbin ; Thomas, T.; Bathish, R.; Kent, M.; Raftery, D.; Arunogiri, S.; Cordaro, F.; Hill, H.; Berk, M. (2019)
      Background: There are currently no approved pharmacotherapies for managing methamphetamine dependence. N-acetylcysteine (NAC) has been found to reduce the craving for methamphetamine and other drugs, but its effect on ...
    • Clinical and demographic characteristics of people who smoke versus inject crystalline methamphetamine in Australia: Findings from a pharmacotherapy trial
      McKetin, Rebecca ; Quinn, B.; Higgs, Peter ; Berk, M.; Dean, O.M.; Turner, A.; Kelly, P.J.; Lubman, D.I.; Carter, G.; Baker, A.L.; Manning, V.; Thomas, T.; Bathish, R.; Raftery, D.; Saunders, L.; Wrobel, A.; Meehan, A.; Sinclair, B.; Reid, D.; Arunogiri, S.; Hill, H.; Cordaro, F.; Dietze, Paul (2021)
      Introduction and Aims: There has been a rapid increase in smoking crystalline methamphetamine in Australia. We compare the clinical and demographic characteristics of those who smoke versus inject the drug in a cohort of ...
    • A systematic review of risk factors for methamphetamine-associated psychosis
      Arunogiri, S.; Foulds, J.; McKetin, Rebecca; Lubman, D. (2018)
      Objective: Chronic methamphetamine use is commonly associated with the development of psychotic symptoms. The predictors and correlates of methamphetamine-associated psychosis are poorly understood. We sought to systematically ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.